[1]
|
国家卫生健康委办公厅. 原发性肝癌诊疗指南(2022年版) [J]. 临床肝胆病杂志, 2022, 38(2): 288-303.
|
[2]
|
Llovet, J.M., Kelley, R.K., Villanueva, A., et al. (2021) Hepatocellular Carcinoma. Nature Reviews Disease Primers, 7, Article No. 6. https://doi.org/10.1038/s41572-020-00240-3
|
[3]
|
Cai, C., Zhang, Y., Hu, X., et al. (2021) CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma. Frontiers in Oncology, 11, Article ID: 721644. https://doi.org/10.3389/fonc.2021.721644
|
[4]
|
Jiang, Z., Wei, Z., Chen, J., et al. (2022) BZW2, CDT1 and IVD Act as Biomarkers for Predicting Hepatocellular Carcinoma. Current Cancer Drug Targets.
|
[5]
|
Yu, Z., Wang, R., Chen, F., et al. (2018) Five Novel Oncogenic Signatures Could Be Utilized as AFP-Related Diagnostic Biomarkers for Hepatocellular Carcinoma Based on Next-Generation Sequencing. Digestive Diseases and Sciences, 63, 945-957. https://doi.org/10.1007/s10620-018-4961-3
|
[6]
|
Dube, J.P., Azzi, Z., Semionov, A., et al. (2019) Imaging of Post Transthoracic Needle Biopsy Complications. The Canadian Association of Radiologists Journal, 70, 156-163. https://doi.org/10.1016/j.carj.2018.08.006
|
[7]
|
Tian, G., Kong, D., Jiang, T., et al. (2020) Complications after Per-cutaneous Ultrasound-Guided Liver Biopsy: A Systematic Review and Meta-Analysis of a Population of More than 12,000 Patients from 51 Cohort Studies. Journal of Ultrasound in Medicine, 39, 1355-1365. https://doi.org/10.1002/jum.15229
|
[8]
|
Chen, Y., Qin, X., Long, L., et al. (2020) Diagnostic Value of Gd-EOB-DTPA-Enhanced MRI for the Expression of Ki67 and Microvascular Density in Hepatocellular Carcinoma. Journal of Magnetic Resonance Imaging, 51, 1755-1763.
https://doi.org/10.1002/jmri.26974
|
[9]
|
Maslowska, K.H., Makiela-Dzbenska, K., Mo, J.Y., et al. (2018) High-Accuracy Lagging-Strand DNA Replication Mediated by DNA Polymerase Dissociation. Proceedings of the Na-tional Academy of Sciences of the United States of America, 115, 4212-4217. https://doi.org/10.1073/pnas.1720353115
|
[10]
|
Costa, A. and Diffley, J.F.X. (2022) The Initiation of Eukaryotic DNA Replication. Annual Review of Biochemistry, 91, 107-131. https://doi.org/10.1146/annurev-biochem-072321-110228
|
[11]
|
Guerrero-Puigdevall, M., Fernandez-Fuentes, N. and Frigola, J. (2021) Stabilisation of Half MCM Ring by Cdt1 during DNA Insertion. Nature Communications, 12, Ar-ticle No. 1746. https://doi.org/10.1038/s41467-021-21932-8
|
[12]
|
Zhang, H. (2021) Regulation of DNA Replication Licensing and Re-Replication by Cdt1. International Journal of Molecular Sciences, 22, Article No. 5195. https://doi.org/10.3390/ijms22105195
|
[13]
|
Karantzelis, N., Petropoulos, M., De Marco, V., et al. (2022) Small Molecule Inhibitor Targeting CDT1/Geminin Protein Complex Promotes DNA Damage and Cell Death in Cancer Cells. Frontiers in Pharmacology, 13, Article ID: 860682. https://doi.org/10.3389/fphar.2022.860682
|
[14]
|
Rona, G. and Pagano, M. (2023) CDT1, a Licensing Factor That Limits Rereplication. Molecular Cell, 83, 1-3.
https://doi.org/10.1016/j.molcel.2022.11.019
|
[15]
|
Lin, Y.C. and Prasanth, S.G. (2021) Replication Initiation: Im-plications in Genome Integrity. DNA Repair, 103, Article ID: 103131. https://doi.org/10.1016/j.dnarep.2021.103131
|
[16]
|
Houben, R., Ebert, M., Hesbacher, S., et al. (2020) Merkel Cell Polyomavirus Large T Antigen Is Dispensable in G2 and M-Phase to Promote Proliferation of Merkel Cell Carcinoma Cells. Viruses, 12, Article No. 1162.
https://doi.org/10.3390/v12101162
|
[17]
|
Liontos, M., Koutsami, M., Sideridou, M., et al. (2007) Deregulated Overexpression of hCdt1 and hCdc6 Promotes Malignant Behavior. Cancer Research, 67, 10899-10909. https://doi.org/10.1158/0008-5472.CAN-07-2837
|
[18]
|
Siril, Y.J., Kouketsu, A., Oikawa, M., et al. (2019) Im-munohistochemical Assessment of Chromatin Licensing and DNA Replication Factor 1, Geminin, and Gamma-H2A.X in Oral Epithelial Precursor Lesions and Squamous Cell Carcinoma. Journal of Oral Pathology & Medicine, 48, 888-896. https://doi.org/10.1111/jop.12925
|
[19]
|
Mahadevappa, R., Neves, H., Yuen, S.M., et al. (2017) The Prognostic Significance of Cdc6 and Cdt1 in Breast Cancer. Scientific Reports, 7, Article No. 985. https://doi.org/10.1038/s41598-017-00998-9
|
[20]
|
Wang, C., Che, J., Jiang, Y., et al. (2022) CDT1 Facilitates Me-tastasis in Prostate Cancer and Correlates with Cell Cycle Regulation. Cancer Biomarkers, 34, 459-469. https://doi.org/10.3233/CBM-210389
|
[21]
|
Petropoulos, M., Champeris, T.S., Nikou, S., et al. (2022) Cdt1 Over-expression Drives Colorectal Carcinogenesis through Origin Overlicensing and DNA Damage. The Journal of Pathology, 259, 10-20. https://doi.org/10.1002/path.6017
|
[22]
|
饶圣祥, 胡道予, 宦怡, 等. 肝胆特异性MRI对比剂钆塞酸二钠临床应用专家共识[J]. 临床肝胆病杂志, 2016, 32(12): 2236-2241.
|
[23]
|
Inchingolo, R., Faletti, R., Grazioli, L., et al. (2018) MR with Gd-EOB-DTPA in Assessment of Liver Nodules in Cirrhotic Patients. World Journal of Hepa-tology, 10, 462-473. https://doi.org/10.4254/wjh.v10.i7.462
|
[24]
|
Li, J., Wang, J., Lei, L., et al. (2019) The Diag-nostic Performance of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging and Contrast-Enhanced Mul-ti-Detector Computed Tomography in Detecting Hepatocellular Carcinoma: A Meta-Analysis of Eight Prospective Stud-ies. European Radiology, 29, 6519-6528.
https://doi.org/10.1007/s00330-019-06294-6
|
[25]
|
Murakami, T., Sofue, K. and Hori, M. (2022) Diagnosis of Hepatocellular Carcinoma Using Gd-EOB-DTPA MR Imaging. Magnetic Resonance in Medical Sciences, 21, 168-181. https://doi.org/10.2463/mrms.rev.2021-0031
|
[26]
|
Motosugi, U., Bannas, P., Sano, K., et al. (2015) Hepatobiliary MR Contrast Agents in Hypovascular Hepatocellular Carcinoma. Journal of Magnetic Resonance Imaging, 41, 251-265. https://doi.org/10.1002/jmri.24712
|
[27]
|
Choi, J.Y., Lee, J.M. and Sirlin, C.B. (2014) CT and MR Imaging Diagno-sis and Staging of Hepatocellular Carcinoma: Part II. Extracellular Agents, Hepatobiliary Agents, and Ancillary Imaging Features. Radiology, 273, 30-50.
https://doi.org/10.1148/radiol.14132362
|
[28]
|
Ding, F., Huang, M., Ren, P., et al. (2023) Quantitative Information from Gadobenate Dimeglumine-Enhanced MRI Can Predict Proliferative Subtype of Solitary Hepatocellular Carcinoma: A Multicenter Retrospective Study. European Radiology. https://doi.org/10.1007/s00330-023-10227-9
|
[29]
|
Ichikawa, S., Morisaka, H., Omiya, Y., et al. (2022) Distinction between Hepatocellular Carcinoma and Hypervascular Liver Metastases in Non-Cirrhotic Patients Using Gadoxetate Disodium-Enhanced Magnetic Resonance Imaging. The Canadian Association of Radiologists Journal, 73, 639-646. https://doi.org/10.1177/08465371221085516
|
[30]
|
Semaan, S., Vietti Violi, N., Lewis, S., et al. (2020) Hepatocel-lular Carcinoma Detection in Liver Cirrhosis: Diagnostic Performance of Contrast-Enhanced CT vs. MRI with Extracel-lular Contrast vs. Gadoxetic Acid. European Radiology, 30, 1020-1030. https://doi.org/10.1007/s00330-019-06458-4
|
[31]
|
Haimerl, M., Utpatel, K., Gotz, A., et al. (2021) Quantification of Contrast Agent Uptake in the Hepatobiliary Phase Helps to Differentiate Hepatocellular Carcinoma Grade. Scientific Re-ports, 11, Article No. 22991.
https://doi.org/10.1038/s41598-021-02499-2
|
[32]
|
莫志英, 廖锦元. 钆塞酸二钠增强MRI肝胆期评估肝细胞癌分化程度的价值[J]. 医学影像学杂志, 2022, 32(8): 1301-1305.
|
[33]
|
Yang, T., Wei, H., Wu, Y., et al. (2023) Pre-dicting Histologic Differentiation of Solitary Hepatocellular Carcinoma Up to 5 cm on Gadoxetate Disodium-Enhanced MRI. Insights Imaging, 14, Article No. 3.
https://doi.org/10.1186/s13244-022-01354-w
|
[34]
|
Peng, Z., Jiang, M., Cai, H., et al. (2016) Gd-EOB-DTPA-Enhanced Magnetic Resonance Imaging Combined with T1 Mapping Predicts the Degree of Differenti-ation in Hepatocellular Carcinoma. BMC Cancer, 16, Article No. 625.
https://doi.org/10.1186/s12885-016-2607-4
|
[35]
|
Choi, S.Y., Kim, S.H., Park, C.K., et al. (2018) Imaging Features of Gadoxetic Acid-Enhanced and Diffusion-Weighted MR Imaging for Identifying Cytokeratin 19-Positive Hepatocellu-lar Carcinoma: A Retrospective Observational Study. Radiology, 286, 897-908. https://doi.org/10.1148/radiol.2017162846
|
[36]
|
陈闯, 何健, 伏旭, 等. 术前普美显增强核磁共振成像对肝细胞癌微血管侵犯的预测价值[J]. 中国普通外科杂志, 2022, 31(7): 896-904.
|
[37]
|
Min, J.H., Lee, M.W., Park, H.S., et al. (2020) Interobserver Variability and Diagnostic Performance of Gadoxetic Acid-Enhanced MRI for Predicting Mi-crovascular Invasion in Hepatocellular Carcinoma. Radiology, 297, 573-581.
https://doi.org/10.1148/radiol.2020201940
|
[38]
|
Yang, Y., Fan, W., Gu, T., et al. (2021) Radiomic Features of Multi-ROI and Multi-Phase MRI for the Prediction of Microvascular Invasion in Solitary Hepatocellular Carcinoma. Frontiers in Oncology, 11, Article ID: 756216.
https://doi.org/10.3389/fonc.2021.756216
|
[39]
|
Liu, Z., Yang, S., Chen, X., et al. (2022) Nomogram Development and Validation to Predict Ki-67 Expression of Hepatocellular Carcinoma Derived from Gd-EOB-DTPA-Enhanced MRI Combined with T1 Mapping. Frontiers in Oncology, 12, Article ID: 954445. https://doi.org/10.3389/fonc.2022.954445
|
[40]
|
Yan, Y., Lin, X.S., Ming, W.Z., et al. (2023) Radiomic Analysis Based on Gd-EOB-DTPA Enhanced MRI for the Preoperative Prediction of Ki-67 Expression in Hepatocellular Carci-noma. Academic Radiology.
https://doi.org/10.1016/j.acra.2023.07.019
|